Introduction
Neonatal sepsis refers to systemic infection of the newborn. It is characterized by a constellation of a nonspecific symptomatology in association with bacteremia. Prompt recognition, appropriate antimicrobial therapy and judicious supportive care are the key determinants of positive outcome in this serious pediatric emergency. In developing countries, sepsis including meningitis, respiratory infections, diarrhea, and neonatal tetanus are the commonest cause of mortality responsible for 30-50 per cent of 5 million total neonatal deaths each year. It is estimated that almost 20 per cent of all neonates develop infection and approximately 1% die of the serious systemic infections. [1] Depending on the onset of symptoms neonatal sepsis is categorized as early (EOS) or late onset sepsis (LOS). Majority (85%) of newborns with EOS present within 24 hours, 5% present at 24-48 hours, and a smaller percentage of patients present between 48 hours and 6 days of life. [2] Early onset sepsis usually presents as respiratory distress and pneumonia within the first 72 hours of life and is associated with acquisition of microorganisms from the mother either transplacentaly or during delivery. The main organisms responsible are GBS, Escherichia Coli, K. pneumoniae, S.aureus, Enterococcus, and Chlamydia. [3] Late onset sepsis usually presents as pneumonia or meningitis after 72 hours of life. The source of infection is nursery, community or NICU. [4] Prominent respiratory signs are the presenting features of EOS while LOS has more varied presentations. Signs of sepsis in newborn are non -specific and early diagnosis of neonatal sepsis is still a great challenge as there is no laboratory test with 100% sensitivity and specificity. [5, 6] Blood culture is a gold standard for diagnosis of septicemia with a yield of 8-73% as shown in various studies [7] . The detection of microorganisms in a patient's blood has a great diagnostic and prognostic significance. Many infections in the neonatal age group can only be established on the basis of etiological agent recovered from blood.
[8]
Methods
The study was conducted at the Neonatal Intensive Care Unit of Kamla Nehru hospital, Shimla from May 2012 to April 2013. Newborns (0-28 days) of >30 weeks gestation and >1000grams weight with features suggestive of sepsis constituted the study cohort. Neonates who had received antibacterial therapy within the last 48 hours and those with Respiratory Distress Syndrome (RDS) due to HMD, major congenital anomalies, haemolytic jaundice and inborn error of metabolism were excluded from the study. Each neonate was examined thoroughly and signs and symptoms of the neonate were recorded in the proforma. The gestational age was assessed by period of gestation (POG) and if not known by New Ballard Scoring System. A detailed history including adverse perinatal factors; intra-partum fever (>37.50C), chorioamnionitis, prolonged rupture of membrane (>18 hours) and unclean vaginal examination were recorded in each case. [9] Blood samples of the neonates were collected at the time of admission and before initiation of antibiotic therapy. Blood sampling was done under all aseptic precautions in the NICU. Soon after admission two ml blood sample was taken in EDTA vacutainer and processed for TLC and platelet count by MS -9 (3-part) Coulter hematology autoanalyser. TLC < 5000 or >20,000 /mm3 were considered abnormal. [10] Peripheral blood smears were drawn on clean slides and stained by Giemsa stain. A differential leukocyte count (DLC) was done to obtain the total neutrophil count (TNC), immature neutrophil count (IM), including bands and stabs; and mature neutrophil count. [11] Neutrophils were classified as band forms when there were no nuclear segmentation or when the width of the nucleus at any constriction was not less than one third the width of its widest portion. Band forms together with less mature cell forms were classified as immature polymorphonuclear (PMN) leukocytes. Using these values, I/M and I/T ratios were computed. Neutrophils were further examined for degenerative changes such as toxic granulation, Dohle bodies, and vacuolization on PBS by Giemsa stain. Immature to total neutrophil ratio (IT Ratio) of >0.2 was taken significant. Micro -ESR was done by capillary method. (μ -ESR) ≥15 mm at the end of 1 hour was taken significant. [10, 11] In addition blood for CRP was also tested. Another 1 ml blood sample was inoculated into 5 ml of culture media -brain heart infusion (BHI) broth in all the cases of suspected EOS prior to starting antibiotics and were observed for at least 72 hours before they were reported as sterile. [12, 13] After detailed investigation and culture reports neonates were further categorised into culture positive sepsis or culture negative sepsis. The clinical manifestations and hematological parameters were compared, individually and in combination, with the blood culture result.
Statistical analysis
Sensitivity, specificity, positive and negative predictive values were calculated for each parameter. P values were also calculated for different parameters. Data was statistically analyzed using SPSS software. Majority of the clinical manifestations of the newborns with suspected sepsis included fever ,refusal to feed, lethargy, followed by pneumonia, disseminated intravascular coagulation (DIC), Among the haematological parameters in EOS, toxic granules had a highest sensitivity and Negative Predictive Value (NPV) of 100%, specificity of 61.2% and Positive Predictive Value (PPV) of 32.6% whereas, raised Micro-ESR had a sensitivity of 92.1%, specificity of 80.7%, PPV of 76% and NPV of 93.8% (Table 3 ). In LOS toxic granules had a highest sensitivity and NPV of 100%, specificity of 72.5% and PPV of 41% whereas raised Micro -ESR had a sensitivity of 88.2%, specificity of 79.5%, PPV of 62.5% and NPV of 94.5% (Table 4 ). In our study among the neonatal haematological parameters in both EOS as well as LOS ,TLC, IT Ratio, Toxic granules , platelet count and Micro -ESR were statistically significant (p value <.05) as compared to rest of the parameters which had low sensitivity, specificity, PPV and NPV. 
Observations and Results

Figure 2: Distribution of Micro-organisms in Newborns with BLOOD C/S (+) EOS (n =46) and LOS (n=24).
Outcome
In our study out of 156 neonates with suspected sepsis 99(63.5%) were discharged after treatment and 47(30.1%) died whereas 10(6.4%) left or were discharged against medical advice. Out of 47 deaths, mortality was high in neonates (40%) with EOS as compared to neonates with LOS (14.7%). Major cause of death in EOS was DIC and shock while in LOS it was respiratory failure .As shown in 
Mortality in relation to bacterial isolates
In our study maximum mortality rate of 55.5% was seen in Gram negative sepsis, 33.3% in Gram positive sepsis and 11.1% in fungal sepsis ( Figure  3 and 4) . In blood culture positive EOS group, mortality rate of 76.9% was seen in Klebsiella sepsis which was very high when compared with LOS. Majority (97.6%) of the patients with Klebsiella sepsis had a typical clinical presentation in the form of petechiae over skin, altered nasogastric aspirate, feed intolerance and abdominal distension. Most common cause of death in all these patients was DIC followed by pulmonary haemorrhage and eventually leading to refractory shock. Most specific hematological features in these patients were thrombocytopenia, presence of toxic granules and raised IT ratio. Among the blood culture positive LOS group, E. coli and Staphylococcal sepsis were predominant with a mortality rate of 66.6% each when compared to EOS. E. coli and Staphylococcal sepsis presented with shock and respiratory failure in 85.8% newborns while late onset Klebsiella sepsis had presentation similar to EOS. Most specific hematological features in LOS were leukocytosis (65.4%), toxic granules and raised IT ratio (45.1% each). In our study there were 10(26.3%) neonatal deaths in EOS group with blood culture negative sepsis but had clinical and hematological features suggestive of severe sepsis. There were 4(40%) newborns with clinical presentation like Klebsiella sepsis and also had maternal risk factors for EOS but had a negative blood culture. 
Discussion
The present study aims to evaluate the clinicobacteriological as well as hematological profile of neonates in a tertiary care hospital. This knowledge is a prerequisite in determining the management strategy of neonates with septicemia. The overall incidence of septicemia among the neonates born at KNH during the study period from 1 st April, 2012 -31 st May 2013 came out to be 22.4/1000 live births. Early onset sepsis had an incidence of 6.6/1000 live births which is less than that reported by Chaudhary S et al [14] (17.3 /1000 live birth) from the same institution two decade ago and by Mondal GP et al [13] (15.5/1000 live births).
Overall blood culture positivity in suspected septicaemia in the present study was 44.8% .In EOS blood culture positivity was seen in 48.4% newborns while it was 39.3% in LOS group which is higher than that 17% reported by Willa Antoniette et al [15] (2003) , 12% by Khalada Binte Khair et al [16] (2010), 26.9% by Mane A K et al [17] (2005-2007) this difference in blood culture positivity in different studies may be due to number of factors like prior administration of antibiotics, difference in prevalence of septicaemia in different region, blood sampling technique and amount of blood taken. Incidence of both EOS and LOS was more common in males and LBW neonates which is similar to that reported by A.C. Buch et al [18] (2011), Trotman H et al [19] (2000) and Gheibi S et al [20] (2006). Important adverse maternal factors associated with sepsis in the present study were similar to those studied by Willa Antoniette et al [15] (2003) and Khalada Binte Khair et al [15] (2010). Majority of the neonates with sepsis presented with fever and refusal to feed (41%), pneumonia (31.4%), DIC, UGI bleed & feed intolerance , birth Asphyxia (12.1%) and shock (11.5%) which was in agreement to study done by Dawodu et al [21] (1997) and Fanaroff et al [22] .
Among the most significant haematological parameters in both EOS and LOS, toxic granules, raised Micro-ESR, I/T Ratio>.2, thrombocytopenia and raised TLC were the most significant markers for early diagnosis of neonatal sepsis which was similar to that observed by Singhi Sunit et al [23] . Khalada Binte Khair et al [16] Rodwell et al [24] In present study Gram positive organisms were the cause of septicaemia in 27.1%, Gram negative organisms in 67.1% and Candida in 5.7% of neonates. In early onset sepsis E. coli (34.7%) was the commonest micro-organism whereas, Klebsiella (29.1%) was predominant in LOS. This was similar to that reported by Kumhar GD et al [25] (1996) Chaudhary H et al [26] (2005) Kapoor L [27] (2001) Jain NK et al [28] (2010) whereas a study by Gheibi S et al [20] (2006 ) documented CONS( 54.6%) as the commonest organism to be isolated in the both EOS and LOS.
Overall mortality rate in our study was 30.1% and neonates with EOS(80.8%) had much higher mortality rate than those with LOS (19.2%). Khinchi Y R et al [29] (2009), Tiskumara R et al [30] 2009 reported a mortality of 10.2% and 10.4 % respectfully. In our study preterm, LBW and male neonates in both EOS and LOS had a high mortality rate which was in agreement with the study by Mathur NB et al [31] (1996).
In our study Gram negative sepsis was responsible for a high mortality rate as compared to Gram positive and fungal sepsis which was similar to that reported by Ahmed N U et al [32] 1998 .
Conclusion
Neonatal sepsis is a serious illness associated with high mortality so a high index of suspicion is important in the diagnosis and treatment of neonatal infection because it is hampered by vague & nonspecific clinical manifestation. Study of neonatal clinical and haematological profile is important to predict the risk of septicaemia so that appropriate treatment can be started without any delay in diagnosis. Different neonatal intensive care unit (NICU) show different epidemiological data for neonatal sepsis.
So collection of up-to-date and site specific data is mandatory for appropriate use of antibiotics.
